Lv1
70 积分 2026-01-15 加入
LC–ESI-MS Characterization of Degradents of Brivaracetam; Development and Validation of a Stability-Indicating RP-HPLC Method
2个月前
已关闭
DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL TO PREDICT PLASMA AND BRAIN EXPOSURE FOLLOWING ADMINISTRATION OF VALPROIC ACID AND CLOBAZAM IN COMBINATION TREATMENT REGIMEN FOR DRAVET SYNDROME IN CHILDREN
4个月前
已完结
Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy
4个月前
已完结
Time-dependence of clobazam and N-demethylclobazam kinetics in healthy volunteers
5个月前
已关闭
皖公网安备34019202002308
